A 13-year-old leukemia patient has been brought into full remission during a clinical trial for a groundbreaking new cancer treatment.

The patient, David Stan, is recovering from a devastating diagnosis of acute myeloid leukemia (AML) with a KMT2A genetic mutation.

Led by Dr. Branko Cuglievan, the trial tested a novel combination therapy using the menin inhibitor revumenib, venetoclax, and decitabine/cedazuridine.

Within just two weeks of treatment, David’s leukemia c